NCT01611025Unknown不适用
The Impact on the Hospital's Microbial Ecology Follow the Introduction of Ertapenem and Other Newly Introduced Antibiotic, Using Antibiotic Utilization and Hospital Susceptibility Data Over Time
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 30,000
研究概览
简要总结
This is a retrospective, multicentre, observational study to assess the trends in antibiotic utilization and hospital ecology with respect to susceptibility patterns of selected bacterial isolates to the utilized antibiotics.
详细描述
This is a retrospective, multicentre, observational study to assess the trends in antibiotic utilization and hospital ecology with respect to susceptibility patterns of selected bacterial isolates to the utilized antibiotics.
There will be two sets of data collected: Hospital acquired infection (only the first pathogen cultured of each episode) and All infection (the whole hospital susceptibility data)
Primary Objectives:
- To study the impact of the introduction of ertapenem on the susceptibility pattern of various pathogens to imipenem/meropenem.
- To study the impact of the introduction of ertapenem on the susceptibility of all Gram negative bacilli to antimicrobial agents commonly used in the participated study sites.
- To explore the trend in antimicrobial utilization before and after the introduction of new antimicrobial agents to the hospital formulary during the index period.
Secondary Objectives:
研究设计
- 研究类型
- Observational
- 观察模型
- Ecologic Or Community
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •the susceptibility of Pseudomonas aeruginosa
- •the susceptibility of Escherichia coli (ESBL and Non-ESBL producing strains)
- •the susceptibility of Klebsiella pneumoniae(ESBL and Non-ESBL producing strains)
- •the susceptibility of Enterobacter cloacae
- •the susceptibility of Enterobacter aerogenes
- •the susceptibility of Acinetobacter baumannii
- •antibiotic utilization data of carbapenems: Ertapenem, Meropenem, Imipenem
- •antibiotic utilization data of Penicillins: Piperacillin/Tazobactam
- •antibiotic utilization data of cephalosporins: Ceftriaxone, Cefotaxime, Flomoxef, Cefoperazone, Ceftazidime, cefepime, Cefpirome
- •antibiotic utilization data of Aztreonam,
- •antibiotic utilization data of fluoroquinolones: Ciprofloxacin, Levofloxacin
- •antibiotic utilization data of aminomethylcyclines: Tigecycline
排除标准
- 未提供
研究者
相似试验
Unknown
不适用
Intestinal Microbiota Composition After Antibiotic Treatment in Early LifeMicrobiotaEczemaAtopyNCT02536560Agentschap NL450
已完成
不适用
Impact of Antimicrobial Stewardship in Hospital: Eight Years Review (BONANTIBIO)Good Use of AntibioticsNCT02884687Centre Hospitalier Régional Metz-Thionville18
已完成
不适用
An Epidemiological Study on Antimicrobial Treatment of Nosocomial Infections in Clinical PracticeNosocomial InfectionNCT00864929AstraZeneca1,500
招募中
不适用
Prospective Cohort Study on Antibiotic Course and Efficacy After Two-stage Revision in PJI.Anti-Bacterial AgentsPeriprosthetic Joint InfectionNCT05284318First Affiliated Hospital of Fujian Medical University500
招募中
不适用
Antibiotic-induced Disruption of the MicrobiotaMicrobiotaAntibiotic DisruptionNCT04091282University of Fribourg400
